38982 Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices 

Management and Budget Circular A– 

123, Management’s Responsibility for 

Internal Control. (5) Division of Grants 

Management: Provides leadership and 

oversight in grants management and 

grants management policy to the 

extramural research community and 

AHRQ extramural staff through expert 

guidance, grant analysis and 

negotiation, outreach, and related 

information dissemination in order to 

promote effective stewardship of AHRQ 

extramural funds in support of 

healthcare research. (6) Division of 

Human Capital and Resources 

Management: Provides guidance to the 

Agency regarding all aspects of 

personnel management including staff 

training, workforce planning and 

restructuring, and allocation and 

utilization of human capital resources. 

Serves as liaison to the Equal 

Employment Opportunity service 

provider and to the servicing personnel 

office to ensure the Agency’s human 

capital needs, including recruitment, 

position classification, and 

compensation, are met and properly 

executed. Manages the Agency’s human 

capital reporting function and 

competitive sourcing activities. Manages 

the Agency’s awards and performance 

management program. 

These changes are effective upon date 

of signature. 

Dated: June 19, 2013. 

Carolyn M. Clancy, 

AHRQ Director. 

[FR Doc. 2013–15289 Filed 6–27–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2013–0001] 

Availability of Draft Toxicological 

Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (DHHS). 

ACTION: Notice of availability, and 

request for comments. 

SUMMARY: This notice announces the 

availability of Set 25 Toxicological 

Profiles for review and comment. 

Comments can include additional 

information or reports on studies about 

the health effects of Set 25 substances. 

Although ATSDR considered key 

studies for each of these substances 

during the profile development process, 

this Federal Register notice solicits any 

relevant, additional studies, particularly 

unpublished data. ATSDR will evaluate 

the quality and relevance of such data 

or studies for possible inclusion in the 

profile. ATSDR remains committed to 

providing a public comment period for 

this document as a means to best serve 

public health and our clients. The Set 

25 Toxicological Profile is available 

online at http://www.atsdr.cdc.gov/

toxprofiles/index.asp and 

www.regulations.gov, docket ATSDR– 

2013–0001. 

The Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA), as amended by 

the Superfund Amendments and 

Reauthorization Act of 1986 (SARA), 

§ 104(i)(3), [42 U.S.C. 9604(i)(3)], directs 

the ATSDR administrator to prepare 

toxicological profiles of priority 

hazardous substances and, as necessary, 

to revise and publish each updated 

toxicological profile. 

DATES: To be considered, comments on 

the draft toxicological profiles must be 

received not later than September 30, 

2013. Comments received after close of 

the public comment period will be 

considered solely at the discretion of 

ATSDR, based upon what is deemed to 

be in the best interest of the general 

public. 

ADDRESSES: You may submit comments, 

identified by docket number ASTDR– 

2013–0001, by any of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.reguations.gov. Follow the 

instructions for submitting comments. 

• Mail: Division of Toxicology and 

Health and Human Sciences, 1600 

Clifton Rd. NE., MS F57, Atlanta, GA. 

30333. 

Instructions: All submissions received 

must include the agency name and 

docket number for this notice. All 

relevant comments will be posted 

without change. Because all public 

comments regarding ATSDR 

toxicological profiles are available for 

public inspection, no confidential 

business information or other 

confidential information should be 

submitted in response to this notice. 

Refer to the section Submission of 

Nominations (below) for specific 

information required. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Delores Grant, Division of Toxicology 

and Human Health Sciences, 1600 

Clifton Rd. NE., MS F–57, Atlanta, GA 

30333. Phone: 770–488–3351. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act (SARA) (Pub. L. 

99–499) amends the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA or Superfund) (42 U.S.C. 9601 

et seq.) by establishing certain 

responsibilities for ATSDR and the U.S. 

Environmental Protection Agency (U.S. 

EPA) with regard to hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List (NPL). As part of these 

responsibilities, the ATSDR 

administrator must prepare 

toxicological profiles for substances 

enumerated on the priority list of 

hazardous substances. This list 

identifies 275 hazardous substances 

which, according to ATSDR and U.S. 

EPA, pose the most significant potential 

threat to human health. The availability 

of the revised priority list of 275 

hazardous substances was announced in 

the Federal Register on March 6, 2008 

(73 FR 12178). In addition, ATSDR has 

the authority to prepare toxicological 

profiles for substances not found at sites 

on the National Priorities List, in an 

effort to ‘‘. . . establish and maintain 

inventory of literature, research, and 

studies on the health effects of toxic 

substances’’ under CERCLA Section 

104(i)(1)(B). This is also to respond to 

requests for consultation under section 

104(i)(4), and as otherwise necessary to 

support the site-specific response 

actions conducted by ATSDR. 

Each profile will include an 

examination, a summary, and an 

interpretation of available toxicological 

information and epidemiological 

evaluations. This information and these 

data identify the levels of significant 

human exposure for the substance and 

for the associated health effects. The 

profiles must also include a 

determination of whether adequate 

information on the health effects of each 

substance is available or is in the 

process of development. If adequate 

information is not available, ATSDR, in 

cooperation with the National 

Toxicology Program (NTP), is required 

to ensure the initiation of a program of 

research to determine such health 

effects. 

All toxicological profiles issued as 

‘‘Drafts for Public Comment’’ represent 

ATSDR’s best efforts to provide 

important toxicological information on 

priority hazardous substances. 

Set 25 toxicological profiles: 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices 38983 

Name CAS 

1 ........................................... Hexachlorobenzene (UPDATE) ........................................................................................................ 118–74–1 

2 ........................................... Endosulfan (UPDATE) ...................................................................................................................... 115–29–7 

Endosulfan sulfate ............................................................................................................................ 1031–07–8 

Endosulfan-alpha .............................................................................................................................. 95–99–98 

Endosulfan-beta ................................................................................................................................ 33213–65–9 

3 ........................................... 1,1-Dichloroethane (UPDATE) .......................................................................................................... 75–34–3 

4 ........................................... Dinitrotoluenes (DNT) (UPDATE).

2,3-DNT ............................................................................................................................................. 602–01–7 

2,4-DNT ............................................................................................................................................. 121–14–2 

2,5-DNT ............................................................................................................................................. 619–15–8 

2,6-DNT ............................................................................................................................................. 606–20–2 

3,4-DNT ............................................................................................................................................. 610–39–9 

3,5-DNT ............................................................................................................................................. 618–85–9 

Dated: June 21, 2013. 

Sascha Chaney, 

Acting Director, Office of Policy, Planning 

and Evaluation, National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2013–15523 Filed 6–27–13; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP–STAC) 

Correction: This notice was published 

in the Federal Register on June 21, 

2013, Volume 78, Number 120, Page 

37543. The name of the committee was 

inadvertently stated as Board of 

Scientific Counselors, National Center 

for Injury Prevention and Control, (BSC, 

NCIPC) and the name of the Committee 

should read World Trade Center Health 

Program Scientific/Technical Advisory 

Committee (WTCHP–STAC), 

Contact Person for More Information: 

Paul Middendorf, Senior Health 

Scientist, 1600 Clifton Rd. NE., MS: E– 

20, Atlanta, GA 30329; telephone (404) 

498–2548 (this is not a toll-free 

number); email: pmiddendorf@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office Centers for Disease Control and 

Prevention. 

[FR Doc. 2013–15455 Filed 6–27–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10105, CMS– 

10467, CMS–10469, CMS–10325 and CMS– 

10330] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by July 29, 2013. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–6974 OR Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/ 

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal Agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Reinstatement with change of a 

previously approved collection; Title of 


tkelley on DSK3SPTVN1PROD with NOTICES